Prospect News: News for Luye Pharma Group Ltd.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with L > Issuers starting with L, CV only > All stories on Luye Pharma Group Ltd. > Stories on Luye Pharma Group Ltd., CV only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Luye Pharma Group Ltd.

12/16/2024	CV	New Issue: Luye Pharma prices $50 million tranche B of 5.85% convertibles due 2025 at par
10/30/2024	CVPP	New Issue: Luye Pharma lists $100 million of convertibles, with $50 million expansion next
7/7/2023	CV	New Issue: Luye Pharma issues $180 million five-year convertible notes to yield 6.25%, up 26.1%
6/27/2023	CV	Luye Pharma talks $180 million five-year convertibles to yield 5.75%-6.25%, up 26.10%-31.27%
7/11/2022	CVLM	Luye Pharma noteholders put $291.61 million of convertibles due 2024
6/29/2020	CV	Luye Pharma shifts conversion price of 1.5% convertibles due 2024
9/5/2019	CV	Luye Pharma adjusts conversion price of 1.5% convertibles due 2024
6/24/2019	CV	New Issue: Luye Pharma prices $300 million five-year convertibles to yield 1.5%, up 40%

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.